Pasithea Therapeutics Corp.
KTTA
$0.7174
$0.00030.04%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -14.75% | 11.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.04% | 12.88% | |||
| Operating Income | -3.04% | -12.88% | |||
| Income Before Tax | -4.29% | -12.13% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -4.29% | -12.13% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -4.29% | -12.13% | |||
| EBIT | -3.04% | -12.88% | |||
| EBITDA | -3.18% | -13.58% | |||
| EPS Basic | 59.12% | 36.39% | |||
| Normalized Basic EPS | 59.12% | 36.40% | |||
| EPS Diluted | 59.12% | 36.39% | |||
| Normalized Diluted EPS | 59.12% | 36.40% | |||
| Average Basic Shares Outstanding | 155.12% | 76.28% | |||
| Average Diluted Shares Outstanding | 155.12% | 76.28% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||